Taken together with these previous studies and our findings, CCL5 secreted by stromal cells may contribute to tumor progression by activating CCR3 expressed in carcinoma cells and regulating downstream pathways such as ERK signaling in breast carcinoma tissues. The gene discussed is CCR3; the disease is neoplasm.